AGN-151586 Dose-Ranging Study for Treatment of Glabellar Lines

Condition:   Glabellar Lines Interventions:   Drug: AGN-151586;   Drug: Placebo Sponsor:   Allergan Not yet recruiting

Source: ClinicalTrials.gov - September 19, 2019 Category: Research Source Type: clinical trials